4 Healthcare Stock Stories Making Midweek Medical Waves

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Eli Lilly and Company (NYSE:LLY): Closing price $51.37

United States regulators are examining the injectable form of the antipsychotic Zyprexa, subsequent to the deaths of two patients, three to four days after receiving the drug. The two patients were given intramuscular injections of Zyprexa Relprevv and were later discovered to have very high levels of the drug in their systems. An FDA statement on Wednesday indicated that such levels may cause delirium, cardiac arrest and arrhythmias, and coma or loss of consciousness. However, the  agency is not pronouncing the deaths the result of overdoses, and said that the patients had not been given an inappropriate amount of the drug. Lilly spokesman Morry Smulevitz commented via email that “based on the information available to us, we are unable to conclude whether the two deaths were related to administration of Zyprexa Relprevv. However, we are continuing to evaluate this important safety issue and will communicate any clinically significant safety information that affects the product.”

Are these stocks a buy or sell? Let us help you decide. LLY

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business